-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-04-01
AVTR:NYE- (USD)
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 15.8Change
-0.41 (-2.53)%Market Cap
USD 11.92BVolume
7.47MVerdict
Verdict
Values as of: 2025-04-01
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 15.8Change
-0.41 (-2.53)%Market Cap
USD 11.92BVolume
7.47MVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
BDX | Becton Dickinson and Company |
+0.38 (+0.17%) |
USD 65.91B |
ALC | Alcon AG |
-0.11 (-0.12%) |
USD 46.01B |
RMD | ResMed Inc |
+0.70 (+0.31%) |
USD 34.14B |
BAX | Baxter International Inc |
-0.37 (-1.09%) |
USD 18.71B |
ATR | AptarGroup Inc |
+1.43 (+0.96%) |
USD 10.16B |
TFX | Teleflex Incorporated |
+1.08 (+0.77%) |
USD 6.39B |
STVN | Stevanato Group SpA |
+0.09 (+0.43%) |
USD 5.88B |
BLCO | Bausch + Lomb Corp |
+0.25 (+1.77%) |
USD 5.64B |
WRBY | Warby Parker Inc |
-0.04 (-0.22%) |
USD 2.55B |
INFU | InfuSystems Holdings Inc |
-0.04 (-0.75%) |
USD 0.13B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
COPP | Sprott Copper Miners ETF | 10.10 % | 0.00 % |
-0.07 (-0.60%) |
N/A |
CEBS:XETRA | iShares Copper Miners UCI.. | 5.61 % | 0.00 % |
-0.04 (-0.60%) |
USD 0.05B |
WIRE:AU | Global X Copper Miners ET.. | 5.25 % | 0.00 % |
-0.01 (-0.60%) |
N/A |
COPG:LSE | Global X Copper Miners UC.. | 5.14 % | 0.00 % |
-0.27 (-0.60%) |
USD 0.15B |
4COP:XETRA | Global X Copper Miners UC.. | 5.13 % | 0.00 % |
-0.31 (-0.60%) |
USD 0.09B |
XMET:AU | BetaShares Energy Transit.. | 4.85 % | 0.00 % |
-0.06 (-0.60%) |
N/A |
COPA | Themes Copper Miners ETF | 4.57 % | 0.00 % |
-0.14 (-0.60%) |
USD 0.50M |
COPX:SW | Global X Copper Miners UC.. | 4.56 % | 0.00 % |
-0.03 (-0.60%) |
N/A |
D6AT:XETRA | Global X Disruptive Mater.. | 4.46 % | 0.00 % |
-0.13 (-0.60%) |
N/A |
GMTL:AU | Global X Green Metal Mine.. | 4.40 % | 0.00 % |
+0.12 (+-0.60%) |
N/A |
COPX:LSE | Global X Copper Miners UC.. | 4.31 % | 0.00 % |
-0.07 (-0.60%) |
N/A |
DMAT | Global X Disruptive Mater.. | 3.67 % | 0.00 % |
-0.06 (-0.60%) |
USD 4.90M |
SETM:LSE | 3.14 % | 0.00 % |
N/A |
N/A | |
CRIT | Optica Rare Earths & Crit.. | 2.63 % | 0.00 % |
N/A |
USD 3.25M |
BSJO | 0.00 % | 0.42 % |
N/A |
N/A | |
COPX | Global X Copper Miners ET.. | 0.00 % | 0.65 % |
-0.24 (-0.60%) |
USD 2.69B |
IVOV | Vanguard S&P Mid-Cap 400 .. | 0.00 % | 0.20 % |
+1.24 (+-0.60%) |
USD 0.87B |
HYDW | Xtrackers Low Beta High Y.. | 0.00 % | 0.25 % |
+0.15 (+-0.60%) |
USD 0.19B |
PQIN | 0.00 % | 0.00 % |
N/A |
N/A | |
IESZ:LSE | 0.00 % | 0.00 % |
N/A |
N/A | |
EXV6:F | 0.00 % | 0.00 % |
N/A |
N/A | |
EXV6:XETRA | iShares STOXX Europe 600 .. | 0.00 % | 0.00 % |
-0.41 (-0.60%) |
USD 0.37B |
BRHY | BlackRock High Yield ETF | 0.00 % | 0.00 % |
+0.10 (+-0.60%) |
USD 0.10B |
Market Performance vs. Industry/Classification (Medical Instruments & Supplies) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -25.01% | 17% | F | 7% | C- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -25.01% | 17% | F | 7% | C- | ||
Trailing 12 Months | |||||||
Capital Gain | -36.75% | 22% | F | 8% | B- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -36.75% | 22% | F | 7% | C- | ||
Trailing 5 Years | |||||||
Capital Gain | 27.83% | 67% | D+ | 39% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 27.83% | 67% | D+ | 28% | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 7.86% | 76% | C+ | 61% | D- | ||
Dividend Return | 7.86% | 76% | C+ | 54% | F | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 43.08% | 33% | F | 21% | F | ||
Risk Adjusted Return | 18.24% | 67% | D+ | 34% | F | ||
Market Capitalization | 11.92B | 71% | C- | 88% | B+ |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This stock has shown below median revenue growth in the previous 5 years compared to its sector